Literature DB >> 26323080

The Authors Reply.

Katherine Wesseling-Perry1.   

Abstract

Mesh：

Year:  2015        PMID： 26323080     DOI： 10.1038/ki.2015.219

Source DB:  PubMed          Journal:  Kidney Int        ISSN： 0085-2538            Impact factor:   10.612


× No keyword cloud information.
  8 in total

1.  FGF23 induces left ventricular hypertrophy.

Authors:  Christian Faul; Ansel P Amaral; Behzad Oskouei; Ming-Chang Hu; Alexis Sloan; Tamara Isakova; Orlando M Gutiérrez; Robier Aguillon-Prada; Joy Lincoln; Joshua M Hare; Peter Mundel; Azorides Morales; Julia Scialla; Michael Fischer; Elsayed Z Soliman; Jing Chen; Alan S Go; Sylvia E Rosas; Lisa Nessel; Raymond R Townsend; Harold I Feldman; Martin St John Sutton; Akinlolu Ojo; Crystal Gadegbeku; Giovana Seno Di Marco; Stefan Reuter; Dominik Kentrup; Klaus Tiemann; Marcus Brand; Joseph A Hill; Orson W Moe; Makoto Kuro-O; John W Kusek; Martin G Keane; Myles Wolf
Journal:  J Clin Invest       Date:  2011-10-10       Impact factor: 14.808

2.  Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice.

Authors:  Emily G Farrow; Xijie Yu; Lelia J Summers; Siobhan I Davis; James C Fleet; Matthew R Allen; Alexander G Robling; Keith R Stayrook; Victoria Jideonwo; Martin J Magers; Holly J Garringer; Ruben Vidal; Rebecca J Chan; Charles B Goodwin; Siu L Hui; Munro Peacock; Kenneth E White
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-17       Impact factor: 11.205

3.  Ferric citrate hydrate for the treatment of hyperphosphatemia in nondialysis-dependent CKD.

Authors:  Keitaro Yokoyama; Hideki Hirakata; Takashi Akiba; Masafumi Fukagawa; Masaaki Nakayama; Kenichi Sawada; Yuji Kumagai; Geoffrey A Block
Journal:  Clin J Am Soc Nephrol       Date:  2014-01-09       Impact factor: 8.237

4.  Fibroblast growth factor 23 and Inflammation in CKD.

Authors:  Jair Munoz Mendoza; Tamara Isakova; Ana C Ricardo; Huiliang Xie; Sankar D Navaneethan; Amanda H Anderson; Lydia A Bazzano; Dawei Xie; Matthias Kretzler; Lisa Nessel; L Lee Hamm; Lavinia Negrea; Mary B Leonard; Dominic Raj; Myles Wolf
Journal:  Clin J Am Soc Nephrol       Date:  2012-05-03       Impact factor: 8.237

5.  The influence of glomerular filtration rate and age on fibroblast growth factor 23 serum levels in pediatric chronic kidney disease.

Authors:  Justine Bacchetta; Laurence Dubourg; Jérome Harambat; Bruno Ranchin; Pauline Abou-Jaoude; Simone Arnaud; Marie-Christine Carlier; Michel Richard; Pierre Cochat
Journal:  J Clin Endocrinol Metab       Date:  2010-02-15       Impact factor: 5.958

6.  Repression of osteocyte Wnt/β-catenin signaling is an early event in the progression of renal osteodystrophy.

Authors:  Yves Sabbagh; Fabiana Giorgeti Graciolli; Stephen O'Brien; Wen Tang; Luciene Machado dos Reis; Susan Ryan; Lucy Phillips; Joseph Boulanger; Wenping Song; Christina Bracken; Shiguang Liu; Steven Ledbetter; Paul Dechow; Maria Eugenia F Canziani; Aluizio B Carvalho; Vanda Jorgetti; Rosa M A Moyses; Susan C Schiavi
Journal:  J Bone Miner Res       Date:  2012-08       Impact factor: 6.741

7.  Patterns of FGF-23, DMP1, and MEPE expression in patients with chronic kidney disease.

Authors:  Renata C Pereira; Harald Juppner; Carlos E Azucena-Serrano; Ora Yadin; Isidro B Salusky; Katherine Wesseling-Perry
Journal:  Bone       Date:  2009-08-11       Impact factor: 4.398

8.  Primary osteoblast-like cells from patients with end-stage kidney disease reflect gene expression, proliferation, and mineralization characteristics ex vivo.

Authors:  Renata C Pereira; Anne M Delany; Nadine M Khouzam; Richard E Bowen; Earl G Freymiller; Isidro B Salusky; Katherine Wesseling-Perry
Journal:  Kidney Int       Date:  2014-10-29       Impact factor: 10.612
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.